: Scientists use CRISPR-Cas systems and synthetic gene circuits to give microbes "if-then" logic, allowing them to release medicine only when they detect specific pathological markers.

: Strategies for moving from lab-grown strains to commercial production .

The book Microbial Engineering for Therapeutics , edited by Mrutyunjay Suar , provides a comprehensive look at these advancements. It covers:

The field of microbial engineering is transforming from simple probiotic supplements into a sophisticated "living therapeutics" platform. Modern research focuses on reprogramming bacteria, fungi, and viruses to act as dynamic biological systems that can sense disease signals and deliver targeted treatments in real-time.

: "Smart" microbes are being developed as living diagnostics that can monitor health from within the gut and flag issues before symptoms appear. Featured Resource: "Microbial Engineering for Therapeutics"